Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Frede, N; Rieger, E; Lorenzetti, R; Venhoff, AC; Kanne, AM; Finzel, S; Jandova, I; Glaser, C; Thiel, J; Voll, RE; Venhoff, N.
Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms.
RMD Open. 2023; 9(2): Doi: 10.1136/rmdopen-2022-002912 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG


Co-Autor*innen der Med Uni Graz
Thiel Jens

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

OBJECTIVES: Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) may have a profound impact on sleep and health-related quality of life. The aim of this study was to assess sleep quality and quality of life and determine associated factors in patients treated with spondyloarthritides (SpA). METHODS: Cross-sectional questionnaire-based assessment of sleep behaviour, quality of life, functional impairment and depression (Regensburg Insomnia Scale, WHO Quality of Life questionnaire, Funktionsfragebogen Hannover questionnaire, Beck Depression Inventory II, Patient health questionnaire 9) and retrospective medical chart analysis of a monocentric cohort of 330 patients with SpA (n=168 PsA and n=162 axSpA). RESULTS: 46.6% of patients with SpA demonstrated abnormal sleep behaviour. Linear regression models showed HLA-B27 positivity, Bath Ankylosing Spondylitis Disease Activity Index, depressive symptoms, functional capacity and disease duration to be predictive of insomnia symptoms in axSpA, respectively, depressive symptoms, female sex and Disease Activity Score 28 in patients with PsA. Patients with unrestful sleep had a significantly reduced health-related quality of life (p<0.001) as well as significantly more depressive symptoms (p<0.001). Satisfaction with health was rated significantly lower (p<0.001), indicating poor sleep as a burden on general well-being.In particular, female patients had a significantly worse sleep quality with a prolonged sleep latency (p=0.009), increased sleep disturbances (p=0.014) and unrestful sleep (p<0.001) as well as a reduced physical and mental health-related quality of life (p=0.015, p<0.001) and more depressive symptoms (p=0.015). CONCLUSION: Despite treatment, many patients with SpA demonstrate abnormal sleep behaviour with symptoms of insomnia and a reduced quality of life with significant differences between male and female patients. An interdisciplinary and holistic approach may be needed to address unmet needs.
Find related publications in this database (using NLM MeSH Indexing)
Humans - administration & dosage
Male - administration & dosage
Female - administration & dosage
Arthritis, Psoriatic - complications, epidemiology
Quality of Life - administration & dosage
Spondylitis, Ankylosing - administration & dosage
Depression - epidemiology, etiology
Retrospective Studies - administration & dosage
Cross-Sectional Studies - administration & dosage
Sleep Initiation and Maintenance Disorders - epidemiology, etiology
Spondylarthritis - complications, diagnosis, epidemiology
Axial Spondyloarthritis - administration & dosage
Sleep - administration & dosage

© Med Uni Graz Impressum